NovAccess Global Inc. (OTCMKTS:XSNX – Get Free Report) saw a significant decrease in short interest in March. As of March 15th, there was short interest totalling 400 shares, a decrease of 98.3% from the February 29th total of 24,000 shares. Based on an average daily volume of 972,800 shares, the days-to-cover ratio is currently 0.0 days.
NovAccess Global Price Performance
Shares of NovAccess Global stock opened at $0.01 on Friday. NovAccess Global has a 12 month low of $0.01 and a 12 month high of $0.22. The stock has a market capitalization of $303,000.00, a P/E ratio of -0.10 and a beta of 1.57. The business has a 50 day simple moving average of $0.02 and a two-hundred day simple moving average of $0.04.
NovAccess Global (OTCMKTS:XSNX – Get Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The company reported $0.01 earnings per share for the quarter.
About NovAccess Global
NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.
Recommended Stories
- Five stocks we like better than NovAccess Global
- Stock Dividend Cuts Happen Are You Ready?
- 3 Value Stocks Too Small For Buffett’s Portfolio
- Do ETFs Pay Dividends? What You Need to Know
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- Retail Stocks Investing, Explained
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.
